CHINA PHARMA HOLDINGS, INC. Gain (Loss) on Sale of Derivatives
CHINA PHARMA HOLDINGS, INC. (CPHI) reported Gain (Loss) on Sale of Derivatives of $0 for the 12-month period ending 2012-12-31, per its 10-K filed 2013-03-14.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnSaleOfDerivatives · last filed 2013-03-14
- CHINA PHARMA HOLDINGS, INC. gain (loss) on sale of derivatives for the quarter ending 2012-12-31 was $0.00.
- CHINA PHARMA HOLDINGS, INC. gain (loss) on sale of derivatives for the quarter ending 2012-09-30 was $0.00.
- CHINA PHARMA HOLDINGS, INC. gain (loss) on sale of derivatives for the quarter ending 2012-06-30 was $0.00, a 100.00% decline year-over-year.
- CHINA PHARMA HOLDINGS, INC. gain (loss) on sale of derivatives for the quarter ending 2012-03-31 was $0.00, a 100.00% decline year-over-year.
- CHINA PHARMA HOLDINGS, INC. gain (loss) on sale of derivatives for fiscal 2012 was $0.00, a 100.00% decline from fiscal 2011.
- CHINA PHARMA HOLDINGS, INC. gain (loss) on sale of derivatives for fiscal 2011 was $934.26K, a 41.20% decline from fiscal 2010.
- CHINA PHARMA HOLDINGS, INC. gain (loss) on sale of derivatives for fiscal 2010 was $1.59M.
| Period end | Gain (Loss) on Sale of Derivatives 3 month | Gain (Loss) on Sale of Derivatives 6 month | Gain (Loss) on Sale of Derivatives 9 month | Gain (Loss) on Sale of Derivatives 12 month |
|---|---|---|---|---|
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-14 | $0.00 derived: sum of 2 quarters · filed 2013-03-14 | $0.00 derived: sum of 3 quarters · filed 2013-03-14 | $0.00 10-K · filed 2013-03-14 |
| 2012-09-30 | $0.00 10-Q · filed 2012-11-14 | $0.00 derived: sum of 2 quarters · filed 2012-11-14 | $0.00 10-Q · filed 2012-11-14 | $0.00 derived: sum of 4 quarters · filed 2013-03-14 |
| 2012-06-30 | $0.00 10-Q · filed 2012-08-14 | $0.00 10-Q · filed 2012-08-14 | $0.00 derived: sum of 3 quarters · filed 2013-03-14 | $0.00 derived: sum of 4 quarters · filed 2013-03-14 |
| 2012-03-31 | $0.00 10-Q · filed 2012-05-14 | $0.00 derived: sum of 2 quarters · filed 2013-03-14 | $0.00 derived: sum of 3 quarters · filed 2013-03-14 | $256.76K derived: sum of 4 quarters · filed 2013-03-14 |
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-14 | $0.00 derived: sum of 2 quarters · filed 2013-03-14 | $256.76K derived: sum of 3 quarters · filed 2013-03-14 | $934.26K 10-K · filed 2013-03-14 |
| 2011-09-30 | $0.00 10-Q · filed 2012-11-14 | $256.76K derived: sum of 2 quarters · filed 2012-11-14 | $934.26K 10-Q · filed 2012-11-14 | $727.95K derived: sum of 4 quarters · filed 2012-11-14 |
| 2011-06-30 | $256.76K 10-Q · filed 2012-08-14 | $934.26K 10-Q · filed 2012-08-14 | $727.95K derived: sum of 3 quarters · filed 2012-08-14 | $1.16M derived: sum of 4 quarters · filed 2012-08-14 |
| 2011-03-31 | $677.50K 10-Q · filed 2012-05-14 | $471.19K derived: sum of 2 quarters · filed 2012-05-14 | $900.88K derived: sum of 3 quarters · filed 2012-05-14 | $1.71M derived: sum of 4 quarters · filed 2012-05-14 |
| 2010-12-31 | -$206.31K derived: 10-K 12 month − 10-Q/A 9 month · filed 2012-03-14 | $223.38K derived: sum of 2 quarters · filed 2012-03-14 | $1.03M derived: sum of 3 quarters · filed 2012-03-14 | $1.59M 10-K · filed 2012-03-14 |
| 2010-09-30 | $429.69K 10-Q/A · filed 2012-03-06 | $1.24M derived: sum of 2 quarters · filed 2012-03-06 | $1.80M 10-Q/A · filed 2012-03-06 | |
| 2010-06-30 | $807.00K 10-Q/A · filed 2011-09-06 | $1.37M 10-Q/A · filed 2011-09-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |